DOC Healthpeak Properties
Permanent stock page ↗Real Estate · S&P 500
Next earnings: Mon 1 Feb 2027 · estimated
What 22 analyst firms say about Healthpeak Properties: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
23 rated views · 24 analyst/firm records · 22 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8032
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8038
Recent analyst activity · last 90 days
Our tracked history has 16 reports on DOC from 13 analyst firms in the last 90 days (22 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 2 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays lowered its target from $24.00 (set 31 Aug 2026) to $21.00 on 13 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Marie Ferguson | Hold | 18 Aug 2026 | — |
| Baird | Amanda Sweitzer | Buy | 13 Aug 2026 | 24.00 USD |
| Baird | Wesley Golladay | Buy | 13 Aug 2026 | 24.00 USD |
| Barclays | Richard Hightower | Hold | 13 Oct 2026 | 21.00 USD |
| BMO Capital Markets | John P Kim | Buy | 19 Oct 2026 | 24.00 USD |
| BMO Capital Markets | Juan Sanabria | Buy | 15 Jun 2026 | 24.00 USD |
| BNP Paribas Exane | Nathan D Crossett | Buy | 15 May 2026 | 23.00 USD |
| Cantor Fitzgerald | Richard Anderson | Hold | 6 Aug 2026 | Conflicting reports · excluded |
| Citigroup | Nick Joseph | Hold | 11 Aug 2026 | 22.00 USD |
| Evercore ISI | James Kammert | Hold | 12 Aug 2026 | 22.00 USD |
| Goldman Sachs | Julien Blouin | Hold | 9 Jan 2026 | 17.00 USD |
| Jefferies | Joe Dickstein | Hold | 15 Sep 2026 | Conflicting reports · excluded |
| JPMorgan | Michael Mueller | Hold | 24 Jun 2026 | 21.00 USD |
| KeyBanc Capital Markets | Austin Wurschmidt | Hold | 1 Jul 2026 | — |
| Mizuho | Vikram Malhotra | Buy | 6 Jul 2026 | 24.00 USD |
| Morgan Stanley | Richard Hill | Hold | 11 Jun 2026 | 22.00 USD |
| Raymond James | David Rodgers | Hold | 5 Oct 2026 | — |
| RBC Capital Markets | Michael Carroll | Buy | 10 Aug 2026 | 24.00 USD |
| Scotiabank | Nicholas Yulico | Hold | 27 May 2026 | 21.00 USD |
| UBS | Michael W Goldsmith | Hold | 13 Oct 2026 | 20.00 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Sep 2026 | — |
| Wells Fargo | James Feldman | Hold | 19 Oct 2026 | 19.00 USD |
| Wolfe Research | Andrew Rosivach | Buy | 1 Jul 2026 | 29.00 USD |
| Data feed RESEARCH | Research Team | Hold | 20 May 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:24 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.